LPS is a powerful stimulator of macrophages and induces apoptosis in these cells. Using primary cultures of bone marrow-derived macrophages, we found that the autocrine production of TNF-α has a major function in LPS-induced apoptosis. LPS activates PKC and regulates the different Mitogen-activated protein kinases (MAPK). We aimed to determine its involvement either in the secretion of TNF-α or in the induction of apoptosis. Using specific inhibitors and mice with the gene for PKCε  disrupted, we found that LPS-induced TNF-α-dependent apoptosis is mostly mediated by PKCε, which is not directly involved in the signaling mechanism of apoptosis but rather in the process of TNF-α secretion. In our cell model, all three MAPKs were involved in the regulation of TNF-α secretion, but at different levels. JNK mainly regulates TNF-α transcription and apoptosis, whereas ERK and p38 contribute towards to the regulation of TNF-α production, probably through posttranscriptional mechanisms. Only JNK activity is mediated by PKCε in response to LPS and so plays a major role in TNF-α secretion and LPS-induced apoptosis. We demonstrated in macrophages that LPS involving PKCε regulates JNK activity and produces TNF-α which induces apoptosis.
orthovanadate, 1 mM DTT, 0.5 mM PMSF, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml iodacetamide). 150 µg of total protein were mixed with 75 µl of 20% protein A-sepharose and 1 µl of anti-JNK1 antibody (sc-474, Santa Cruz Biotechnology) in a total volume of 500 µl.
The samples were rotated for 2 hours at 4 o C. The immunocomplexes were washed three times with cold PBS supplemented with 1% NP-40 and 2 mM sodium orthovanadate, once with cold JNK buffer (20 mM Hepes-Na pH 7.5, 20 mM β-glycerophosphate, 20 mM MgCl 2 , 0.1 mM sodium orthovanadate, 2 mM DTT), and resuspended in JNK reaction buffer (JNK buffer supplemented with 1 µg GST-c-Jun (1-169) (Calbiochem, San Diego, CA) and as a substrate, 20 µM ATP, 1 µCi γ-32 P-ATP. The reaction was run for 30 minutes at 30 o C and was then stopped by adding 12 µl of 5xLaemli buffer. The samples were incubated for 3 minutes at 100 o C and separated by 10% SDS-PAGE. After electrophoresis, the gels were fixed in isopropanol:water:acetic acid (25:65:10), dried and exposed to Kodak X-AR films.
RESULTS
In these studies we used bone marrow-derived macrophages, which are a homogeneous population of primary and quiescent cells (12) . Bone marrow macrophages growing in the presence of M-CSF are unevenly distributed in the different phases of the cell cycle. Upon activation with LPS, macrophages stop at the G 0 /G 1 phase of the cell cycle and die through the induction of apoptosis (11, 25) . LPS-induced apoptosis was quantified using an ELISA kit that measures the presence of histone-associated low molecular weight DNA fragments ( Fig.1 ). This technique, used for the quantitative measurement of apoptosis in this cellular model, correlates closely with other methods (67-69). In some experiments, apoptosis was also determined by flow cytometry with DAPI staining or by DNA laddering with 9 qualitatively identical results. The induction of macrophage apoptosis by LPS was time-and dose-dependent (Fig. 1) . The kinetics of induction of apoptosis was very fast with a maximal induction as early as 6 hours after the start of LPS treatment. The levels of apoptosis did not increase any further after 6 hours and up to 24 hours of stimulation (Fig. 1A ).
Maximal induction of apoptosis was obtained at a concentration of 100 ng/ml of LPS (Fig. 1B) , a dose that saturates binding of LPS to its high-affinity receptor, CD14/TLR-4 (46) .
It has been reported that other molecules may also transfer signals at very high doses of LPS
(1-10 µg/ml) (49) . To avoid signaling through other LPS-receptors independent of CD14, in this study we used sub-saturating amounts of LPS (1-10 ng/ml) that already induce apoptosis in macrophages (Fig. 1B) . Moreover, since we are interested in the TNFα-dependent early apoptotic events in response to LPS, we performed all the studies 6-12 hours after LPS treatment. Because iNOS protein expression and NO production after LPS treatment can only be detected after 12-24 hours of treatment, any interference of NO in our results can be excluded (68) . This is also confirmed by the fact that an inhibitor of NO production, SMT, does not reduce LPS-induced apoptosis at 12 hours of treatment (68) . To exclude any possibility of contaminants in the commercial LPS preparation, experiments were repeated using purified LPS (40) and identical results were obtained.
As a high number of LPS-induced processes are dependent on PKC activation in macrophages (21, 33, 54), we studied the effect of PKC inhibition in macrophages. Our previous studies with specific antibodies had revealed that only PKCβ 1 , ε and ξ were present in bone marrow-derived macrophages, whereas the rest of the isozymes were not detected (18). As these cells cannot be transfected efficiently, we used specific chemical inhibitors (13) . When the cells were pre-incubated with the PKC inhibitor calphostin C (10-100 nM) before the addition of LPS, we observed a dose-dependent inhibition of the induction of apoptosis in response to LPS ( Fig. 2A) . The next step was to establish which of the PKC isoforms present in macrophages was involved in LPS-induced apoptosis. To achieve this, we used Bisindolylmaleimyde I (GF109203X), which is a specific inhibitor of conventional PKC (βI), and new PKC (ε). As shown in Fig. 2B , GF109203X inhibits LPS-induced apoptosis, which suggests that one GF-sensitive PKC isoform is involved in the regulation of apoptosis by LPS and also excludes the involvement of atypical PKCζ in LPS-induced apoptosis because the GF109203X doses used in our experiments do not inhibit this isoform (63).
Macrophages were also treated with Gö6976, a selective inhibitor of conventional PKC isoforms, including PKCβ1 (38). Gö6976 did not modify the levels of apoptosis induced by LPS (Fig. 2C ). Taken together, these results suggested that PKC regulates LPS-induced apoptosis and that PKCε is the main PKC isoform involved in this process.
Finally, to check our results further, we analyzed the apoptosis induced by LPS in bone marrow-derived macrophages obtained from mice where the PKCε gene had been disrupted by homologous recombination (PKCε KO). Macrophages from these mice were resistant to LPS-induction of apoptosis (Fig. 2D) , confirming the results obtained with drug inhibitors.
Because we had found in previous studies that TNF-α secretion induced by LPS is mainly responsible for LPS-induced apoptosis (68), we wanted now to determine whether the effect of PKCε on LPS-induced apoptosis is mediated through the induction of TNF-α expression or whether it is a mechanism directly involved with the apoptosis machinery.
Bone marrow macrophages express high levels of TNF-α mRNA after three hours of LPS stimulation (Fig. 3A) . LPS also induces the expression of IL-1β mRNA, partly as a consequence of TNF-α secretion. The inhibition of PKCε by pre-treatment of cells with GF109203X before LPS stimulation resulted in almost complete inhibition of the expression 11 of TNF-α and IL1-β mRNA (Fig. 3A) . Stimulation with LPS also led to high levels of TNF-α protein secretion in the cell culture supernatant, which rose to concentrations close to 4.5 ng/ml (Fig. 3B ). These amounts of TNF-α are clearly sufficient to induce apoptosis in macrophages, because doses between 1 and 10 ng/ml of murine recombinant TNF-α induced significant levels of apoptosis (68) . Again, inhibition of PKCε activity with GF109203X
inhibited the secretion of TNF-α (Fig. 3B) .
Our results suggested that PKCε regulates LPS-induced apoptosis and that there is a correlation with TNF-α production. To determine whether LPS induces PKCε-dependent TNF-α secretion or TNF-α induces the activation of PKCε required for apoptosis, we measured the apoptosis induced by recombinant TNF-α in the presence of GF109203X.
GF109203X did not affect the apoptosis induced by recombinant TNF-α (Fig. 3C ), which suggests that PKCε is involved in the apoptosis induced by LPS through the induction of TNF-α production, but not in the TNF-α signaling pathway that induces apoptosis.
Of macrophages from wild-type animals, macrophages from PKCε KO mice treated with LPS showed lower levels of TNF-α mRNA (Fig. 3D) (Fig. 4A ). These drugs also inhibited the apoptosis induced by LPS (Fig.   4B ). Moreover, when we analyzed TNF-α mRNA expression ( Fig. 4C ) and TNF-α secretion (Fig 4D) , we found that the expression of TNF-α also decreased when cells were incubated with the JNK inhibitors. These results suggest that the JNK pathway can play a role in the expression of TNF-α and the apoptosis induced in response to LPS.
To determine the role of the other two MAP kinases in TNF-α secretion, specific inhibitors of p38 and ERK-1/2 were used. At concentrations of 50 µM of PD98059 and 5 µM of SB203580, activation of ERK and p38, respectively, was blocked in bone marrow macrophages (Fig. 5A ). PD98059 slightly decreased the levels of the TNF-α mRNA after LPS treatment, whereas SB203580 did not modify them (Fig. 5B) . However, the inhibition of the ERK and p38 MAP kinases produces a minor decrease of TNF-α secretion (Fig. 5C ).
Since IL-1β expression is induced in response to secreted TNF-α, the SB and PD pretreatments also reduce the levels of LPS-induced IL-1β mRNA ( Fig. 5B and 5C ). These results suggest that ERK and p38 MAPK regulate TNF-α expression mainly through posttranscriptional mechanisms, as has been reported elsewhere (32, 52, 70) . Obviously, the lower 13 TNF-α secretion derived from the response to these inhibitors also decreased LPS-induced apoptosis ( Fig. 5D ).
Taken together, these results suggested an involvement of PKCε and MAP kinases in the apoptosis induced by LPS through the regulation of TNF-α. Thus, we also wanted to determine whether PKCε was involved in the regulation of MAP kinases, as has already been reported in peritoneal macrophages (11) . As the differential time-course of ERK is crucial in relation to proliferation or differentiation (61), we performed a selected MAPK analysis over time. We observed that JNK activity induced by LPS was clearly inhibited by GF109203X at all times ( Fig. 6A ), but not by Gö6976 (Fig. 6B ), which suggested that PKCε mediates the LPS-induced activation of the JNK pathway. This was confirmed by a large reduction in JNK activity after LPS treatment in macrophages from KO PKCε mice ( Fig. 6C ), while ERK and p38 were not inhibited.
We further extended our analysis to determine the involvement of PKCε in the activation of ERK and p38 MAP kinase pathways by LPS. GF109203X slightly decreased the levels of ERK or p38 activity over short time periods, but led to a significant extension of activity during the response of macrophages to LPS (Figs. 6 D and E). Again, Gö6976 did not modify the activation of ERK or p38 kinases induced by LPS. Thus, PKCε inhibition did not block the activation of ERK and p38 kinases but promoted a long activation pattern. In this context, GF109203X did not inhibit JNK activation (Fig. 7B ) or TNF-α−induced-IL-1-β expression (Fig. 7C ). TNF-α (10 ng/ml) did not induce the activation of ERK or p38, either. Moreover, the fact that curcumin or SP600125 did not affect apoptosis induced by recombinant TNF-α indicated that JNK activation in macrophages in response to TNF-α did not modulate the signaling cascade leading to apoptosis in response to TNF-α.
Our results suggest that in response to LPS there is a new signaling pathway that regulates TNF-α production in macrophages; LPS activates PKCε, which in turn activates the c-jun kinase and induces the production of TNF-α with the subsequent triggering of apoptosis.
DISCUSSION
In a previous study we established that bone marrow-derived macrophages die through apoptosis in response to LPS, predominantly through autocrine secretion of TNF-α ( The ultimate fate of a cell exposed to TNF-α is determined by signal integration between its different effectors, including IκB kinase (IKK), c-Jun N-terminal protein kinase (JNK) and caspases (6) . Activation of caspases is required for apoptosis (59), whereas activation of IKK inhibits apoptosis through the transcription factor NF-κB, whose target genes include inhibitors of caspases (64). JNK activates the transcription factor c-Jun/AP-1 as well as other targets (14) . However, the function of JNK activation in apoptosis induced by TNF-α is less clear (34, 45) .
In our experiments, the fact that PKC and MAPK inhibitors blocked apoptosis induced by LPS and TNF-α expression, but did not inhibit apoptosis induced by recombinant TNF-α treatment, indicates that PKCε and the three MAP kinases can modulate LPS-induced apoptosis through the production of TNF-α but not through a direct effect on the apoptotic mechanism. In endothelial cells, JNK was involved in TNF-α-induced apoptosis (30).
However, in other cell models no involvement of MAP kinases or PKCε has been described in the TNF-α-induced pathway leading to apoptosis (9, 16, 29). Recently, research conducted on fibroblasts has found that the NF-κB pathway negatively modulates JNK activation mediated by TNF-α and contributes to the inhibition of apoptosis (17, 58) . However, our results with curcumin do not confirm these observations. The differences could be due to different responses of macrophages and fibroblasts to TNF-α (35, 68), since TNF-α induces apoptosis in macrophages without inhibiting protein synthesis or the NFκB pathway.
Our results suggest that only JNK is down-stream of the PKCε activity. This supports the existence of a new pathway in macrophages where LPS induces PKCε which activates JNK, which in turn modulates TNF-α expression at transcriptional level and thus mediates apoptosis induced by LPS. Kinase activity experiments support our hypothesis, since JNK activity induced by LPS is inhibited when macrophages are pre-treated with the PKC inhibitor GF109203X. Our results were confirmed by the use of mice with a disrupted PKCε gene (40) .
These mice showed lower resistance to infection by Gram-positive or -negative bacteria, and the peritoneal macrophages showed a dramatic reduction of LPS-induced TNF-α production with a partial reduction of LPS-induced ERK or p38 MAP kinase activities (40) . Our results confirm and extend these observations. In our experiments, the bone marrow-derived macrophages from these mice were resistant to LPS-induced apoptosis, and both TNF-α secretion and JNK activity were lower. This suggests preferential induction of JNK activity over the other two MAP kinases. 
